AHR profile · all as-reported value updates
American Healthcare REIT, Inc. (AHR) as-reported value updates
Descriptive filing record — not investment advice. This page compares two SEC XBRL-filed values for the same fiscal period. It does not state why the values differ and is not a rating, score, or recommendation. See Disclaimer.
Reported values for the same fiscal period can differ between filings for many routine reasons: re-presentation for discontinued operations, adoption of new accounting standards, reclassifications, changes in rounding precision, and amendments. This ledger records that the filed values differ; it does not and cannot determine why. Both filings are linked below so the reader can consult the source.
Ledger table figure
| Metric | FY | Earliest XBRL-filed value | Currently on file | Difference | Difference % | Label | Filing links | Notes |
|---|---|---|---|---|---|---|---|---|
| Net income | 2020 | -18,057,000 | 2,163,000 | 20,220,000 | +111.98% | revised comparative figure | 0001632970-21-000028 0001632970-23-000029 | 3 filed observations examined for this concept and period. |
| Share buybacks | 2019 | 8,609,000 | 89,888,000 | 81,279,000 | +90.42% | revised comparative figure | 0001632970-20-000016 0001632970-22-000020 | 3 filed observations examined for this concept and period. |
| Cash and cash equivalents | 2020 | 17,411,000 | 113,212,000 | 95,801,000 | +84.62% | revised comparative figure | 0001632970-21-000028 0001632970-24-000039 | 4 filed observations examined for this concept and period. |
| Operating cash flow | 2020 | 35,495,000 | 219,156,000 | 183,661,000 | +83.80% | revised comparative figure | 0001632970-21-000028 0001632970-23-000029 | 3 filed observations examined for this concept and period. |
| Liabilities | 2020 | 540,416,000 | 2,160,114,000 | 1,619,698,000 | +74.98% | revised comparative figure | 0001632970-21-000028 0001632970-22-000020 | 2 filed observations examined for this concept and period. |
| Net income | 2019 | -18,769,000 | -4,965,000 | 13,804,000 | +73.55% | revised comparative figure | 0001632970-20-000016 0001632970-22-000020 | 3 filed observations examined for this concept and period. |
| Share buybacks | 2020 | 6,214,000 | 23,107,000 | 16,893,000 | +73.11% | revised comparative figure | 0001632970-21-000028 0001632970-23-000029 | 3 filed observations examined for this concept and period. |
| Cash and cash equivalents | 2019 | 15,290,000 | 53,149,000 | 37,859,000 | +71.23% | revised comparative figure | 0001632970-20-000016 0001632970-23-000029 | 4 filed observations examined for this concept and period. |
| Dividends paid | 2019 | 20,905,000 | 62,612,000 | 41,707,000 | +66.61% | revised comparative figure | 0001632970-20-000016 0001632970-22-000020 | 3 filed observations examined for this concept and period. |
| Operating cash flow | 2019 | 39,540,000 | 117,454,000 | 77,914,000 | +66.34% | revised comparative figure | 0001632970-20-000016 0001632970-22-000020 | 3 filed observations examined for this concept and period. |
| Assets | 2020 | 1,092,773,000 | 3,234,937,000 | 2,142,164,000 | +66.22% | revised comparative figure | 0001632970-21-000028 0001632970-22-000020 | 2 filed observations examined for this concept and period. |
| Cash and cash equivalents | 2018 | 14,388,000 | 35,132,000 | 20,744,000 | +59.05% | revised comparative figure | 0001632970-19-000034 0001632970-22-000020 | 4 filed observations examined for this concept and period. |
| Stockholders' equity | 2020 | 548,958,000 | 866,108,000 | 317,150,000 | +36.62% | revised comparative figure | 0001632970-21-000028 0001632970-22-000020 | 2 filed observations examined for this concept and period. |
| Revenue | 2017 | 21,838,000 | 33,333,000 | 11,495,000 | +34.49% | revised comparative figure | 0001632970-18-000035 0001632970-20-000016 | 3 filed observations examined for this concept and period. |
| Dividends paid | 2020 | 17,837,000 | 26,997,000 | 9,160,000 | +33.93% | revised comparative figure | 0001632970-21-000028 0001632970-23-000029 | 3 filed observations examined for this concept and period. |